Track topics on Twitter Track topics that are important to you
AstraZeneca’s MedImmune subsidiary has agreed to exclusively license and develop bi-specific and multi-specific immuno-oncology antibody products from Compugen’s pipeline, through a collaboration ...
In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to David Malek, Vice Preident of Business Development of BioLineRx.
Compugen has entered into an exclusive license agreement with MedImmune.
AstraZeneca’s MedImmune has inked a deal with Israeli group Compugen giving it access to the firm’s experimental bi- and multi-specific antibody products.
Do we really have a good understanding of how life works at a molecular level? Martin Gerstel, Chairman of Compugen, explains how the company has created a computer that can accurately model the behav...
MedImmune LLC and Compugen Ltd. penned an agreement for the development of bispecific and multi-specific antibody therapies for cancer.
Compugen Ltd. netted $20mm through a registered direct offering of 5.3mm ordinary shares at $3.95 (a 4% premium). Investors also received five-year warrants to purchase 4.3mm shares at $4.74. JMP Secu...
Israel-based drug maker Compugen Ltd. and pharma giant AstraZeneca have teamed up to develop bi-specific and multi-specific immuno-oncology antibody products.
BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...
BioLineRx's ultimate mission is to improve the health of people throughout the world with compounds that make for better and longer lives. Founded in 2003 by leaders in the Israeli life-sciences secto...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based...
Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology ...
We have published hundreds of BioLineRx Ltd. and Compugen Ltd. news stories on BioPortfolio along with dozens of BioLineRx Ltd. and Compugen Ltd. Clinical Trials and PubMed Articles about BioLineRx Ltd. and Compugen Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLineRx Ltd. and Compugen Ltd. Companies in our database. You can also find out about relevant BioLineRx Ltd. and Compugen Ltd. Drugs and Medications on this site too.
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...